# Assessment of Efficacy and Safety of Amicomed®, for the Management of Essential Hypertension

> **NCT06091176** · NA · UNKNOWN · sponsor: **Newel Health SRL** · enrollment: 316 (estimated)

## Conditions studied

- Essential Hypertension
- Primary Hypertension

## Interventions

- **DEVICE:** Amicomed®
- **DEVICE:** Digital Placebo
- **OTHER:** Usual Care

## Key facts

- **NCT ID:** NCT06091176
- **Lead sponsor:** Newel Health SRL
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-11-01
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 316 (ESTIMATED)
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06091176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06091176, "Assessment of Efficacy and Safety of Amicomed®, for the Management of Essential Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06091176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*